MX2010006091A - Intermediarios y metodos para hacer analogos de macrolido de zearalenona. - Google Patents
Intermediarios y metodos para hacer analogos de macrolido de zearalenona.Info
- Publication number
- MX2010006091A MX2010006091A MX2010006091A MX2010006091A MX2010006091A MX 2010006091 A MX2010006091 A MX 2010006091A MX 2010006091 A MX2010006091 A MX 2010006091A MX 2010006091 A MX2010006091 A MX 2010006091A MX 2010006091 A MX2010006091 A MX 2010006091A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- intermediates
- making
- zearalenone
- macrolide analogs
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- 239000003120 macrolide antibiotic agent Substances 0.000 title abstract 2
- MBMQEIFVQACCCH-UHFFFAOYSA-N trans-Zearalenon Natural products O=C1OC(C)CCCC(=O)CCCC=CC2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-UHFFFAOYSA-N 0.000 title 1
- MBMQEIFVQACCCH-QBODLPLBSA-N zearalenone Chemical compound O=C1O[C@@H](C)CCCC(=O)CCC\C=C\C2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-QBODLPLBSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940041033 macrolides Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1240807P | 2007-12-07 | 2007-12-07 | |
| US1241107P | 2007-12-07 | 2007-12-07 | |
| US1240907P | 2007-12-07 | 2007-12-07 | |
| US8004808P | 2008-07-11 | 2008-07-11 | |
| PCT/US2008/013498 WO2009075818A1 (en) | 2007-12-07 | 2008-12-08 | Intermediates and methods for making zearalenone macrolide analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010006091A true MX2010006091A (es) | 2010-06-25 |
Family
ID=40445478
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010006091A MX2010006091A (es) | 2007-12-07 | 2008-12-08 | Intermediarios y metodos para hacer analogos de macrolido de zearalenona. |
| MX2010005999A MX2010005999A (es) | 2007-12-07 | 2008-12-08 | Intermediarios en la sintesis de analogos de macrolidos de zearalenona. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010005999A MX2010005999A (es) | 2007-12-07 | 2008-12-08 | Intermediarios en la sintesis de analogos de macrolidos de zearalenona. |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US8507696B2 (enExample) |
| EP (2) | EP2231634B1 (enExample) |
| JP (3) | JP5496908B2 (enExample) |
| CN (2) | CN101889006B (enExample) |
| BR (2) | BRPI0820958B1 (enExample) |
| CA (2) | CA2708141C (enExample) |
| IL (2) | IL205954A (enExample) |
| MX (2) | MX2010006091A (enExample) |
| RU (2) | RU2478630C2 (enExample) |
| WO (2) | WO2009075823A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2478065C (en) | 2002-03-08 | 2013-01-08 | Eisai Co. Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| CN105748465A (zh) | 2007-07-25 | 2016-07-13 | 卫材R&D管理株式会社 | 用于治疗癌症的多激酶抑制剂 |
| CA2708141C (en) * | 2007-12-07 | 2016-07-05 | Eisai R & D Management Co., Ltd. | Intermediates and methods for making zearalenone macrolide analogs |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL69666A (en) * | 1982-09-13 | 1987-10-20 | Lilly Co Eli | 20-amino-20-deoxo-5-o-mycaminosyl-23-o-mycinosyltylonolide derivatives,their preparation and veterinary antibiotic use |
| GB9225396D0 (en) | 1992-12-04 | 1993-01-27 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US5795910A (en) | 1994-10-28 | 1998-08-18 | Cor Therapeutics, Inc. | Method and compositions for inhibiting protein kinases |
| SK286592B6 (sk) * | 1997-07-08 | 2009-01-07 | Bristol-Myers Squibb Company | Derivát epotilónu, farmaceutický prostriedok s jeho obsahom a jeho použitie |
| JP2004292314A (ja) | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | ケラチノサイト増殖抑制剤 |
| JP2004292315A (ja) | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | Ｔａｋ１阻害剤 |
| US7915306B2 (en) | 2002-03-08 | 2011-03-29 | Eisai Co., Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| CA2478065C (en) * | 2002-03-08 | 2013-01-08 | Eisai Co. Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| US8067412B2 (en) | 2006-08-11 | 2011-11-29 | Universite De Strasbourg | Macrocyclic compounds useful as inhibitors of kinases and HSP90 |
| US8513440B2 (en) * | 2007-06-05 | 2013-08-20 | Universite De Strasbourg | Compositions and methods comprising analogues of radicicol A |
| CN105748465A (zh) | 2007-07-25 | 2016-07-13 | 卫材R&D管理株式会社 | 用于治疗癌症的多激酶抑制剂 |
| TW200924749A (en) * | 2007-07-25 | 2009-06-16 | Eisai R & Amp D Man Co Ltd | Zearalenone macrolide derivatives and uses of the same |
| CA2708141C (en) * | 2007-12-07 | 2016-07-05 | Eisai R & D Management Co., Ltd. | Intermediates and methods for making zearalenone macrolide analogs |
-
2008
- 2008-12-08 CA CA2708141A patent/CA2708141C/en active Active
- 2008-12-08 RU RU2010128103/04A patent/RU2478630C2/ru active
- 2008-12-08 JP JP2010536949A patent/JP5496908B2/ja active Active
- 2008-12-08 US US12/746,675 patent/US8507696B2/en active Active
- 2008-12-08 CN CN2008801195442A patent/CN101889006B/zh active Active
- 2008-12-08 WO PCT/US2008/013512 patent/WO2009075823A1/en not_active Ceased
- 2008-12-08 EP EP08860344.4A patent/EP2231634B1/en active Active
- 2008-12-08 EP EP08860534.0A patent/EP2231635B1/en active Active
- 2008-12-08 CA CA2708143A patent/CA2708143C/en active Active
- 2008-12-08 US US12/746,672 patent/US8350059B2/en active Active
- 2008-12-08 BR BRPI0820958-8A patent/BRPI0820958B1/pt active IP Right Grant
- 2008-12-08 WO PCT/US2008/013498 patent/WO2009075818A1/en not_active Ceased
- 2008-12-08 MX MX2010006091A patent/MX2010006091A/es active IP Right Grant
- 2008-12-08 RU RU2010128096/04A patent/RU2497803C2/ru active
- 2008-12-08 BR BRPI0820953-7A patent/BRPI0820953B1/pt active IP Right Grant
- 2008-12-08 CN CN200880119543.8A patent/CN101889005B/zh active Active
- 2008-12-08 JP JP2010536950A patent/JP5492786B2/ja active Active
- 2008-12-08 MX MX2010005999A patent/MX2010005999A/es active IP Right Grant
-
2010
- 2010-05-25 IL IL205954A patent/IL205954A/en active IP Right Grant
- 2010-05-26 IL IL205983A patent/IL205983A/en active IP Right Grant
-
2013
- 2013-01-03 US US13/733,562 patent/US20130211103A1/en not_active Abandoned
-
2014
- 2014-03-05 JP JP2014042331A patent/JP2014141498A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200745149A (en) | Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments | |
| NZ588884A (en) | Cross-linkers and their uses | |
| WO2009111653A3 (en) | Antiviral therapeutic agents | |
| MX2010004234A (es) | Derivados de purina como ligandos del receptor de adenosina a1. | |
| MX343042B (es) | Compuestos heteroarilicos biciclicos. | |
| SG178952A1 (en) | Chemical compounds | |
| TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
| MY162411A (en) | Crystalline forms of a macrolide, and uses therefor | |
| MX2011005934A (es) | Compuestos organicos. | |
| WO2007133560A3 (en) | Acetylenic heteroaryl compounds | |
| WO2009079008A8 (en) | Benzopyrans and analogs as rho kinase inhibitors | |
| AU2007249926A8 (en) | Monocyclic heteroaryl compounds | |
| MX2009008660A (es) | Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos. | |
| IL199891A (en) | Aqueous preparations of (e) - 2, 4, 6 - trimethoxystyril - 3 - carboxymethylamino - 4 - methoxybenzylsulfone for intravenous administration | |
| TW200602347A (en) | Macrolides and methods for producing same | |
| BRPI0717775B8 (pt) | preparação de estansoporfina de alta pureza em larga escala | |
| WO2009062659A3 (en) | Polymorphs of enantiopure erdosteine | |
| GB0508314D0 (en) | Organic compounds | |
| WO2008110908A8 (en) | Method for preparing hydroxytyrosol derivatives and of hydroxytyrosol | |
| MX2010006091A (es) | Intermediarios y metodos para hacer analogos de macrolido de zearalenona. | |
| MX2009009074A (es) | Macrolidos basados en eritromicina. | |
| WO2008107771A3 (en) | 2',3'-di-o-acyl-5-fluoronucleosides | |
| WO2008104957A3 (en) | Novel polymorphic forms of milnacipran hydrochloride | |
| MX2010003056A (es) | Polimorfos de valomaciclovir. | |
| ZA200903193B (en) | Novel Morphine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |